Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution

Abstract

Members of the APOBEC family of cytidine deaminases show antiviral activities in mammalian cells through lethal editing in the genomes of small DNA viruses, herpesviruses and retroviruses, and potentially to RNA viruses such as coronaviruses. Consistent with the latter, APOBEC-like directional C→U transitions of genomic plus-strand RNA are greatly overrepresented in SARS-CoV-2 genome sequences of variants emerging during the COVID-19 pandemic. A C→U mutational process may leave evolutionary imprints on coronavirus genomes, including extensive homoplasy at sites of editing and reversion at targeted sites, the occurrence of driven amino acid sequence changes in viral proteins with no adaptive value, and, if sustained over longer periods, the previously reported marked global depletion of C and excess of U bases in human coronavirus NL63 genomes. This review synthesizes the current knowledge on APOBEC evolution and function and the evidence of their role in APOBEC-mediated genome editing of SARS-CoV-2 and other coronaviruses.

Highlights

• -

  SARS-CoV-2 sequence variants contain an overabundance of C- > U transitions

• -

  C- > U transitions are the hallmark of the activity of APOBEC cytosine deaminases

• -

  Further work is needed to determine APOBEC's role in coronavirus evolution